Location History:
- Camerino, IT (2000)
- Falerone, IT (2021)
Company Filing History:
Years Active: 2000-2021
Title: Antonio Concetti: Innovator in Inflammation-Related Treatments
Introduction
Antonio Concetti is a notable inventor based in Falerone, Italy. He has made significant contributions to the field of medical research, particularly in the treatment and prevention of inflammation-associated diseases. With a total of 2 patents, his work focuses on innovative methods and compositions that address various inflammatory conditions.
Latest Patents
Concetti's latest patents include "Methods and compositions relating to p62/SQSTM1 for the treatment and prevention of inflammation-associated diseases." This patent presents novel p62 compositions aimed at modulating the expression of proinflammatory cytokines, osteogenic transcription factors, and bone resorptive factors. These compositions are designed for the prophylaxis and treatment of inflammatory diseases, which may include conditions such as osteoporosis, obesity, type 2 diabetes, and various neurodegenerative diseases. Another significant patent is for "Polynucleotide immunogenic agents," which are capable of inducing an immune response towards members of the Epidermal Growth Factor Receptors (EGFR) family.
Career Highlights
Throughout his career, Antonio Concetti has worked with esteemed institutions such as the Università degli Studi di Camerino and Curelab Oncology, Inc. His research has been pivotal in advancing the understanding and treatment of inflammatory diseases, showcasing his dedication to improving health outcomes.
Collaborations
Concetti has collaborated with notable colleagues, including Franco Venanzi and Augusto Amici. These partnerships have further enriched his research and contributed to the development of innovative solutions in the medical field.
Conclusion
Antonio Concetti stands out as a significant figure in the realm of medical innovation, particularly in the treatment of inflammation-related diseases. His patents and collaborative efforts reflect his commitment to advancing healthcare through scientific research and innovation.